PD-0360324

· Pfizer

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PD-0360324, covering 2009-07-14 to 2020-01-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2, Safety, Tolerability, and Efficacy Study of PD 0360324 in Chronic Pulmonary Sarcoidosis [Phase 2]